SciBase Holding AB (publ)
STO:SCIB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
SciBase Holding AB (publ)
Total Current Liabilities
SciBase Holding AB (publ)
Total Current Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
S
|
SciBase Holding AB (publ)
STO:SCIB
|
Total Current Liabilities
kr25m
|
CAGR 3-Years
9%
|
CAGR 5-Years
19%
|
CAGR 10-Years
13%
|
|
|
Elekta AB (publ)
STO:EKTA B
|
Total Current Liabilities
kr13.8B
|
CAGR 3-Years
3%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
|
|
CellaVision AB
STO:CEVI
|
Total Current Liabilities
kr110.9m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
1%
|
CAGR 10-Years
12%
|
|
|
Getinge AB
STO:GETI B
|
Total Current Liabilities
kr13B
|
CAGR 3-Years
3%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
|
|
Arjo AB (publ)
STO:ARJO B
|
Total Current Liabilities
kr3.7B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
N/A
|
|
|
S
|
Stille AB
STO:STIL
|
Total Current Liabilities
kr115.8m
|
CAGR 3-Years
38%
|
CAGR 5-Years
33%
|
CAGR 10-Years
20%
|
|
SciBase Holding AB (publ)
Glance View
SciBase Holding AB is a global medical technology company, which engages in the development and sale of instruments for the detection of skin cancer and other skin diseases. The company is headquartered in Sundbyberg, Stockholm and currently employs 23 full-time employees. The company went IPO on 2015-06-02. The firm specializes in the manufacture of point of care device, called Nevisense, which is aimed to detect of malignant melanoma. Nevisense analyze suspicious lesions by using Electrical Impedance Spectroscopy (EIS) which is applied as an electrical signal to the skin. The diagnostic product is sold in Nordic countries, Belgium, Germany, Great Britain and Australia.
See Also
What is SciBase Holding AB (publ)'s Total Current Liabilities?
Total Current Liabilities
25m
SEK
Based on the financial report for Dec 31, 2025, SciBase Holding AB (publ)'s Total Current Liabilities amounts to 25m SEK.
What is SciBase Holding AB (publ)'s Total Current Liabilities growth rate?
Total Current Liabilities CAGR 10Y
13%
Over the last year, the Total Current Liabilities growth was 6%. The average annual Total Current Liabilities growth rates for SciBase Holding AB (publ) have been 9% over the past three years , 19% over the past five years , and 13% over the past ten years .
